385-391 Cholinergic dysfunction and amnesia in patients with Wernicke-Korsakoff syndrome: A transcranial magnetic stimulation study

Journal of Neural Transmission

Volumn 117, Issue 3, 2010, Pages 385-391

  Nardone, Raffaele ^a,b   Bergmann, Jürgen ^a   De Blasi, Pierpaolo ^c   Kronbichler, Martin ^a   Kraus, Jörg ^a   Caleri, Francesca ^b   Tezzon, Frediano ^b   Ladurner, Günther ^a   Golaszewski, Stefan ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b FRANZ TAPPEINER HOSPITAL   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Afferent inhibition; Amnesia; Cholinergic function; Short latency; Transcranial magnetic stimulation; Wernicke korsakoff syndrome

Indexed keywords

DONEPEZIL; CHOLINE; CHOLINESTERASE INHIBITOR;

ADULT; AGED; AMNESIA; ANTICHOLINERGIC SYNDROME; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; LATENT INHIBITION; MALE; MEMORY; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RECALL; SCORING SYSTEM; SENSORY NERVE; SHORT LATENCY AFFERENT INHIBITION; SHORT TERM MEMORY; SINGLE DRUG DOSE; TRANSCRANIAL MAGNETIC STIMULATION; WERNICKE KORSAKOFF SYNDROME; ALCOHOLISM; BRAIN; DRUG EFFECT; KORSAKOFF PSYCHOSIS; METABOLISM; METHODOLOGY; MIDDLE AGED; NERVE CELL INHIBITION; PATHOPHYSIOLOGY; TIME;

ADULT; ALCOHOLICS; AMNESIA; BRAIN; CHOLINE; CHOLINESTERASE INHIBITORS; FEMALE; HUMANS; KORSAKOFF SYNDROME; MALE; MEMORY; MEMORY, SHORT-TERM; MIDDLE AGED; NEURAL INHIBITION; NEUROPSYCHOLOGICAL TESTS; TIME FACTORS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 77952427477     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-009-0347-1     Document Type: Article

References (46)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. APA, Washington
2. Angunawela II, Barker A. (2001) Anticholinesterase drugs for alcoholic Korsakoff syndrome. Int J Geriatr Psychiatry 16:338-339
3. Arendt T, Allen Y, Sinden J, Schugens MM, Marchbanks RM, Lantos PL, Gray JA (1988) Cholinergic-rich brain transplants reverse alcohol-induced memory deficits. Nature 332:448-450 (Pubitemid 18090246)
4. Arendt T, Bruckner MK, Bigl V, Marcova L (1995) Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. III. The basal forebrain compared with other subcortical areas. J Comp Neurol 351:223-246
5. Bartus RT (2000) On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol. 163:495-529
6. Blokland A (1995) Acetylcholine: a neurotransmitter for learning and memory? Brain Res Brain Res Rev 21:285-300
7. CaineD,HallidayGM,KrilJJ,HarperCG(1997) Operationalcriteriafortheclassificationofchronicalcoholics: identificationofWernicke'sencephalopathy.JNeurolNeurosurgPsychiatry62: 51-60(Pubitemid27047441)
8. Cochrane M, Cochrane A, Jauhar P, Ashton E (2005) Acetylcholinesterase inhibitors for the treatment of Wernicke-Korsakoff syndrome-three further cases show response to donepezil. Alcohol Alcohol 40:151-154 (Pubitemid 40347344)
9. CullenKM,HallidayGM,CaineD,KrilJJ(1997)Thenucleusbasalis(Ch4) inthealcoholicWernicke-Korsakoffsyndrome:reducedcellnumberinbothamnesicandnon- amnesicpatients.JNeurolNeurosurgPsychiatry63:315-320(Pubitemid27412372)
10. Di Lazzaro V, Oliviero A, Profice P, Pennisi MA, Di Giovanni S, Zito G, Tonali P, Rothwell JC (2000) Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex. Exp Brain Res 135:455-461
11. DiLazzaroV,OlivieroA,TonaliPA,MarraC,DanieleA,ProficeP,SaturnoE,PilatoF, MasulloC,RothwellJC(2002) NoninvasiveinvivoassessmentofcholinergiccorticalcircuitsinADusingtranscranialma gneticstimulation.Neurology59:392-397(Pubitemid34857932)
12. Di Lazzaro V, Oliviero A, Pilato F, Saturno E, Dileone M, Marra C, Daniele A, Ghirlanda S, Gainotti G, Tonali PA (2004) Motor cortex excitability to transcranial magnetic stimulation in Alzheimer's disease. J Neurol Neurosurg Psychiatry 75:555-559 (Pubitemid 38406651)
13. Di Lazzaro V, Oliviero A, Pilato F, Saturno E, Dileone M, Marra C, Ghirlanda S, Ranieri F, Gainotti G, Tonali P (2005a) Neurophysiological predictors of long term response to AChE inhibitors in AD patients. J Neurol Neurosurg Psychiatry 76:1064-1069 (Pubitemid 41081276)
14. Di Lazzaro V, Oliviero A, Saturno E, Dileone M, Pilato F, Nardone R, Ranieri F, Musumeci G, Fiorilla T, Tonali P (2005b) Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans. J Physiol 564:661-668 (Pubitemid 40585061)
15. Di Lazzaro V, Pilato F, Dileone M, Tonali PA, Ziemann U (2005c) Dissociated effects of diazepam and lorazepam on short-latency afferent inhibition. J Physiol 569:315-323
16. Di Lazzaro V, Pilato F, Dileone M, Saturno E, Oliviero A, Marra C, Daniele A, Ranieri F, Gainotti G, Tonali PA (2006) In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias. Neurology 66:1111-1.113
17. Dunnett SB, Robbins TW (1992) The functional role of mesotelencephalic dopamine systems. Biol Rev Camb Philos Soc 67:491-518
18. Fujiki M, Hikawa T, Abe T, Ishii K, Kobayashi H (2006) Reduced short latency afferent inhibition in diffuse axonal injury patients with memory impairment. Neurosci Lett 405:226-230 (Pubitemid 44189721)
19. Gibson GE, Jope R, Blass JP (1975) Decreased synthesis of acetylcholine accompanying impaired oxidation of pyruvic acid in rat brain minces. Biochem J 148:17-23
20. Halliday G, Ellis J, Harper C (1992) The locus coeruleus and memory: a study of chronic alcoholics with and without the memory impairment of Korsakoff's psychosis. Brain Res 598:33-37 (Pubitemid 23013041)
21. HallidayG,EllisJ,HeardR,CaineD,HarperC(1993) Brainstemserotonergicneuronsinchronicalcoholicswithandwithoutthememoryimpairmen tofKorsakoffspsychosis.JNeuropatholExpNeurol52:567-579(Pubitemid23335732)
22. Harding AJ, Halliday GM, Ng JL, Harper CG, Kril JJ (1996) Loss of vasopressin-immunoreactive neurons in alcoholics is doserelated and time-dependent. Neuroscience 72:699-708
23. Harding AJ, Wong A, Svoboda M, Kril JJ, Halliday GM (1997) Chronic alcohol consumption does not cause hippocampal neuron loss in humans. Hippocampus 7:78-87 (Pubitemid 27107632)
24. HardingA,HallidayG,CaineD,KrilJ(2000) Degenerationofanteriorthalamicnucleidifferentiatesalcoholicswithamnesia. Brain123(Pt1):141-154(Pubitemid30037976)
25. Harper CG, Kril JJ (1990) Neuropathology of alcoholism. Alcohol Alcohol 25:207-216
26. Hodges H, Allen Y, Sinden J, Mitchell SN, Arendt T, Lantos PL, Gray JA (1991) The effects of cholinergic drugs and cholinergicrich foetal neural transplants on alcohol-induced deficits in radial maze performance in rats. Behav Brain Res 43:7-28
27. Kasa P, Rakonczay Z, Gulya K (1997) The cholinergic system in Alzheimer's disease. Prog Neurobiol 52:511.-535
28. Kopelman MD (1995) The Korsakoff syndrome. Br J Psychiatry 166:1.54-173
29. Kopelman MD, Corn TH (1988) Cholinergic 'blockade' as a model for cholinergic depletion. A comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsakoff syndrome. Brain 111(Pt 5):1079-1110
30. Kril JJ, Halliday GM, Svoboda MD, Cartwright H (1997) The cerebral cortex is damaged in chronic alcoholics. Neuroscience 79:983-998
31. KujiraiT,CaramiaMD,RothwellJC,DayBL,ThompsonPD,FerbertA,WroeS,AsselmanP, MarsdenCD(1993)Corticocorticalinhibitioninhumanmotorcortex.JPhysiol471: 501-519(Pubitemid23345592)
32. Luykx HJ, Dorresteijn LD, Haffmans PM, Bonebakker A, Kerkmeer M, Hendriks VM (2008) Rivastigmine in Wernicke-Korsakoff s syndrome: five patients with rivastigmine showed no more improvement than five patients without rivastigmine. Alcohol Alcohol 43:70-72
33. Mair RG, McEntee WJ (1986) Cognitive enhancement in Korsakoff's psychosis by Clonidine: a comparison with L-dopa and ephedrine. Psychopharmacology (Berl) 88:374-380
34. Manganelli F, Ragno M, Cacchio G, lodice V, Troj ano L, Silvaggio F, Scarcella M, Grazioli M, Santoro L, Perretti A (2008) Motor cortex cholinergic dysfunction, in CADASIL: a transcranial, magnetic demonstration. Clin Neurophysiol 119:351-355 (Pubitemid 50009229)
35. Martin PR, Adinoff B, Lane E, Stapleton JM, Bone GA, Weingartner H, Linnoila M, Eckardt MJ (1995) Fluvoxamine treatment of alcoholic amnestic disorder. Eur Neuropsychopharmacol 5:27-33
36. Mayes AR, Meudell PR, Mann D, Pickering A (1988) Location of lesions in Korsakoff s syndrome: neuropsychological and neuropathological data on two patients. Cortex 24:367-388
37. McEntee WJ, Mair RG (1980) Memory enhancement in Korsakoff's psychosis by Clonidine: further evidence for a noradrenergic deficit. Ann Neurol 7:466-470
38. Nardone R, Marth R, Ausserer H, Bratti A, Tezzon F (2006) Reduced short latency afferent inhibition in patients with Down syndrome and Alzheimer-type dementia. Clin Neurophysiol 117:2204-2210 (Pubitemid 44333280)
39. Rogers SL, Friedhoff LT (1998) Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses. Br J Clin Pharmacol 46(Suppl l):l-6
40. Rossini PM, Barker T, Berardelli A, Caramia MD, Caruso G, Cracco RQ, Dimitrijevic MR, Hallett M, Katayama Y, Lucking CH, Maertens de Noordhout AL, Marsden CD, Murray NMF, Rothwell JC, Swash M, Tomberg C (1994) Non invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical, application: report of IFCN committee. Electroenceph Clin Neurophysiol 91:79-92 (Pubitemid 24246462)
41. Sahin HA, Gurvit IH, Bilgic B, Hanagasi HA, Emre M (2002) Therapeutic effects of an acetylcholinesterase inhibitor (donepezil) on memory in Wernicke-Korsakoff's disease. Clin Neuropharmacol 25:16-20 (Pubitemid 34178243)
42. TokimuraH,DiLazzaroV,TokimuraY,OlivieroA,ProficeP,InsolaA,MazzoneP, TonaliP,RothwellJC(2000) Shortlatencyinhibitionofhumanhandmotorcortexbysomatosensoryinputfromthehand. JPhysiol523(Pt2):503-513(Pubitemid30137656)
43. Victor M, Adams RD, Collins GH (1989) The Wernicke-Korsakoff syndrome and related neurologic disorders due to alcoholism and malnutrition. FA Davies Company, Philadelphia
44. Voytko ML, Olton DS, Richardson RT, Gorman LK, Tobin JR, Price DL (1994) Basal forebrain lesions in monkeys disrupt attention but not learning and memory. J Neurosci 14:167-186
45. Witt ED (1985) Neuroanatomical consequences of thiamine deficiency: a comparative analysis. Alcohol Alcohol 20:201-221
46. Ziemann U (2004) TMS and drugs. Clin Neurophysiol 115:1717-1729